Quantcast Biotech News - Congoo
 
 
Log In
  HEALTH >> BIOTECH    Get our Biotech daily Briefing     
Biological sciences
Biotech
Cancer
Consumer health
Consumer: biking news
Consumer: motoring news
Consumer: recipes
Fitness
Genetics
Health
Healthcare
Human sciences
Medical
Natural health
Pharmaceutical Industry
UK medical
 
 



ZAGG, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results   - 3 Hours ago
ZAGG Inc. (NASDAQ: ZAGG) (www. ZAGG.com), a leading producer of mobile electronics accessories including the popular invisibleSHIELDâ?¢ and ZAGGaudioâ?¢ brands, today announced financial results for the
all 19 news articles >>
  
    



Sequenom Q4 Loss Widens - Update   - 9 Hours ago
3/15/2010 5:35 PM ET RELATED NEWS Trade SQNM now with TOP MARKET NEWS (RTTNews) - Life science company Sequenom, Inc. (SQNM: News ), Monday reported a fourth quarter loss that widened from last year,
  
    




Genzyme inspection finds drug impurity   - 66 Minutes ago
Genzyme Corp. has notified its customers that an impurity has been found in one vial of the drug Cerezyme at its plant in Waterford, Ireland, in what is the latest in a series of manufacturing problems
  
    



Tapping RNA silencing pathways for plant biotechnology   - 3 Hours ago
Plants have evolved a variety of gene silencing pathways mediated by small RNAs. Mostly 21 or 24 nt in size, these small RNAs repress the expression of sequence homologous genes at the transcriptional,
  
    



Sequential Intramolecular Epitope Spreading of Humoral Responses to Human BPAG2   - 4 Hours ago
Journal of Investigative Dermatology 130, 1040 (April 2010). doi:10.1038/jid.2009.309 Authors: Giovanni Di Zenzo, Valentina Calabresi, Edit B Olasz, Giovanna Zambruno
  
    



Sequenom Inc. Q4 2009 Earnings Call Transcript   - 8 Hours ago
4:30 pm ET Executives Ian Clements â?? Senior Director, IR and Corporate Communications Harry Hixson â?? Chairman and CEO Paul Maier â?? Interim CFO Analysts Zarak Khurshid â?? Wedbush Securities Evan
  
    


American Express takes you places Sponsored
The Preferred Rewards Gold Card takes you places. And shows you’ve arrived. Enjoy Gold Card benefits and access while you earn travel rewards fast. Earn 10,000 Membership Rewards® bonus points redeemable for rewards after your first purchase.  Learn More



Maryland May Mandate Biotech Investment   - 9 Hours ago
A new Maryland state law may require the Maryland State Retirement and Pension System to invest nearly 50 million in bioscience and medical technology
  
    



Single Molecule Sequencing Technology Brings Genomic Screening to the Clinical Lab   - 11 Hours ago
Technologies are beginning to emerge that will allow clinical laboratories to deliver genomic sequence data within a few hours rather than in the days or weeks that are currently required. Life Technologies
  
    



Satcon Appoints Chief Financial Officer   - 5 Hours ago
BOSTON--(BUSINESS WIRE)--Satcon Technology Corporation (NASDAQ CM: SATC), a leading provider of utility scale power solutions for the renewable energy market, today announced the appointment of Donald
all 12 news articles >>
  
    


Reach your target audience with AdBlade! Sponsored
- Brand your product
- Create awareness in your product
- Drive traffic

And do it all on a CPC basis of as little as 50 cents.  Try AdBlade and begin reaching your targ.  Learn More



Innate Immune Grants Cephalon Australia License To Develop Antibodies For Asthma,   - 3 Hours ago
Innate Immune, a privately held biotechnology company, has granted Cephalon Australia an exclusive license to develop antibodies for the treatment of asthma and systemic lupus erythematosis (SLE). Cephalon
  
    



Epeius Biotechnologies Receives Notice of Patent Allowance for Tumor-Targeted Cancer   - 3 Hours ago
SAN MARINO, Calif. (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial
  
    



CLC bio releases groundbreaking whole-genome de novo assembler   - 3 Hours ago
The challenge of user-friendliness: None of the current de novo assembly applications for large genomes works through a graphical user-interface. CLC bioâ??s de novo assembler comes with both an intuitive
  
    


Your sponsored post can go right here! Sponsored

Congoo’s B2B information portal now receives over 1 million visits per month.  Congoo provides a highly influential audience comprehensive news and information within their industry.  Reach a coveted audience of senior executives, affluent males and opinion leaders. Get the Media Kit




Sequenom cites progress on problems with key test   - 3 Hours ago
Sequenom said it made significant progress during the fourth quarter in addressing problems related to the mishandling of data for a key Down syndrome test. The San Diego biotechnology company said it
  
    



Bionomics to present at Ultimate Healthcare & Biotechnology Event, March 24   - 3 Hours ago
Leading European investment house Edison Investment Research has provided a new valuation of Bionomics (ASX: BNO) at 55 cents per share.  Current BNO share price is 31 cents. This was based mainly
  
    



BioTech Capital buys back 15k shares   - 3 Hours ago
Source: News Bites BioTech Capital Ltd bought back 15,000 shares for $3,150 on-market on March 15, 2010. Previously 3,394,526 shares have been bought back. There are 4,570,951 shares still to be bought
  
    



Bulgaria Food Products Show High Levels of GMOs   - 5 Hours ago
A higher level of GMOs than the allowed limit was found in 7% of the food products tested by the Sofia public health body RIOKOZ in 2009. A high content of GMOs was found predominantly in sausages, wafers
  
    



DNA microarray analysis of rheumatoid arthritis susceptibility genes identified   - 5 Hours ago
Sugino H et al. This study aims to clarify whether DNA microarray analysis and GWASs produce comparable results with respect to RA susceptibility genes.
  
    



Ricerca Biosciences Finalizes Acquisition of MDS Pharma Services Business 3/11/10   - 5 Hours ago
Ricerca Biosciences, LLC, announced the finalization of the acquisition of the Discovery and Preclinical business of MDS Pharma Services with facilities and almost 600 associates in Bothell, Washington;
  
    



Genzyme, Isis Pharmaceuticals: Phase 3 study of mipomersen in hoFH patients meets   - 5 Hours ago
Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) today announced that data from a phase 3 study of mipomersen in patients with homozygous familial hypercholesterolemia (hoFH)
  
    



Decoded Genome Gives New Hope in Confronting Diseases   - 5 Hours ago
Two research teams have independently decoded the entire genome of patients to find the exact genetic cause of their disease. The approach may offer a new start in the so far disappointing effort to identify
  
    



Cubist Pharmaceuticals President and CEO Michael Bonney Honored by Massachusetts   - 5 Hours ago
Companies mentioned in this article: Cubist Pharmaceuticals, Inc. LEXINGTON, Mass. -- (BUSINESS WIRE) -- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that its President and CEO Michael
all 1 news articles >>
  
    



Immunomedics to Present at Barclays Capital 2010 Global Healthcare Conference   - 5 Hours ago
(GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that Cynthia L.
all 8 news articles >>
  
    



Cephalon Patent Suit Over Amrix Survives Dismissal   - 6 Hours ago
A federal judge has ruled that a patent infringement suit against Anchen Pharmaceuticals Inc. over its plans to make a generic version of Cephalon Inc. muscle relaxant Amrix can go forward, largely denying
  
    



The sexual tug-of-war -- a genomic view   - 6 Hours ago
ScienceDaily (Mar. 15, 2010) â?? The genes that are most beneficial to males are the most disadvantageous for females, and vice versa. However, this genetic conflict between the sexes is important in
  
    



Biotechnology Program Aims to Triple Enrollment in Bay Area, Expanding Opportunities   - 3 Hours ago
A program designed to introduce young women to the fast-growing area of biotechnology has opened its application process to high school girls in the Bay Area. The Perry Outreach Program, which is taught
  
    
*Votes may take up to 30 minutes to influence article rank order


Featured Members
Matthew Pfeffer Matthew Pfeffer
SVP and CFO
Biotech Industry
Gal Shafirstein Gal Shafirstein
Associate Prof.
Biotech Industry
Michele Cunneen Michele Cunneen
Animal research program consultant
Biotech Industry
Jennifer Neiman Jennifer Neiman
Senior Manager, Corporate Communications
Biotech Industry

  Add your Profile
  View more profiles

   




 
 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2010 Congoo.com. All Rights Reserved.